Compare ABCL & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | PRGS |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2020 | 1995 |
| Metric | ABCL | PRGS |
|---|---|---|
| Price | $5.97 | $39.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $8.40 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 7.5M | 987.7K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | 7.79 |
| EPS | N/A | ★ 1.03 |
| Revenue | $75,128,000.00 | ★ $397,572,000.00 |
| Revenue This Year | N/A | $3.70 |
| Revenue Next Year | $21.85 | $1.08 |
| P/E Ratio | ★ N/A | $38.35 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $23.82 |
| 52 Week High | $8.44 | $51.28 |
| Indicator | ABCL | PRGS |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 63.40 |
| Support Level | $5.23 | $39.05 |
| Resistance Level | $6.79 | $44.09 |
| Average True Range (ATR) | 0.61 | 2.08 |
| MACD | -0.23 | 0.09 |
| Stochastic Oscillator | 14.66 | 77.33 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.